dr. gandara discusses pd-l1 as a biomarker in lung cancer
Published 6 years ago • 96 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
1:21
dr. kim discusses pd-l1 as a biomarker in lung cancer
-
1:41
dr. goldberg on pd-l1 as a biomarker in lung cancer
-
1:02
david gandara, md, current thinking regarding testing for pd-l1 biomarker in nsclc patients
-
1:24
dr. lilenbaum on pd-l1 as a predictive biomarker for immunotherapy in lung cancer
-
7:34
pd-l1 as a biomarker in squamous non-small cell lung cancer
-
1:55
dr. gandara on the impact of immunotherapy on the tumor microenvironment in lung cancer
-
2:13
the value of pd-l1 as a biomarker beyond lung cancers
-
5:02
dr blythe adamson: pd-l1 as a predictive biomarker in lung cancer continues to evolve
-
5:06
should pd-l1 be used as a biomarker for immunotherapy in lung cancer?
-
0:53
dr. gandara on measuring tmb in nsclc
-
4:50
nsclc: challenges with pd-l1 as biomarker
-
2:24
dr. weiss on pd-l1 biomarker in lung cancer
-
1:20
dr. david gandara describes exciting new lung cancer research
-
10:20
pd-l1 testing in advanced lung cancer
-
2:03
dr. david gandara discusses multiplexing molecular tests for nsclc
-
2:15
dr. gandara on practice-changing studies in lung cancer
-
1:34
evolving role of pd-l1 as a biomarker
-
1:03
dr. barbara j. gitlitz on why pd-l1 is not a good biomarker for immunotherapy in lung cancer
-
6:21
lung cancer video library - pdl1 as a biomarker for first line